Kathleen S. Wright Associates’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$5.58M Sell
122,451
-300
-0.2% -$13.3K 2.07% 14
2025
Q2
$5.2M Sell
122,751
-150
-0.1% -$5.56K 2.03% 14
2025
Q1
$4.34M Sell
122,901
-330
-0.3% -$12.5K 1.79% 15
2024
Q4
$4.71M Sell
123,231
-2,400
-2% -$90.4K 1.96% 14
2024
Q3
$4.45M Buy
125,631
+151
+0.1% +$4.77K 1.84% 16
2024
Q2
$3.58M Sell
125,480
-3,211
-2% -$89.4K 1.65% 16
2024
Q1
$3.53M Buy
128,691
+1,981
+2% +$53.4K 1.66% 15
2023
Q4
$3.35M Sell
126,710
-6,259
-5% -$142K 1.7% 15
2023
Q3
$2.75M Buy
132,969
+40,962
+45% +$923K 1.54% 16
2023
Q2
$2.06M Sell
92,007
-11,945
-11% -$253K 1.32% 20
2023
Q1
$2.26M Sell
103,952
-20,929
-17% -$471K 1.48% 19
2022
Q4
$2.62M Sell
124,881
-29,040
-19% -$651K 1.77% 15
2022
Q3
$3.39M Buy
153,921
+6,865
+5% +$178K 2.75% 8
2022
Q2
$3.52M Hold
147,056
2.97% 5
2022
Q1
$4.48M Buy
147,056
+186
+0.1% +$5.56K 3.27% 5
2021
Q4
$4.78M Buy
+146,870
New +$4.65M 3.52% 5

Other funds holding BN

Kathleen S. Wright Associates's BN Position: Q3 2025 in Review

Kathleen S. Wright Associates reduced its Brookfield (BN) stake by 0.24% in Q3 2025, selling an estimated $13.3K and leaving 122,451 shares worth $5.58M. The position accounts for 2.07% of the portfolio, ranked #14.

Kathleen S. Wright Associates first reported a position in BN in Q4 2021 and has held it in 16 quarters since. 879 funds tracked by Wall St. Rank hold BN as of Q3 2025.

  • Kathleen S. Wright Associates held 122,451 shares of Brookfield worth $5.58M as of Q3 2025.
  • Kathleen S. Wright Associates sold 300 Brookfield shares in Q3 2025, an estimated $13.3K.
  • Brookfield made up 2.07% of Kathleen S. Wright Associates's portfolio in Q3 2025, its #14 holding.
  • Kathleen S. Wright Associates first reported a position in Brookfield in Q4 2021 and has held it in 16 quarters since.
  • 879 funds tracked by Wall St. Rank held Brookfield as of Q3 2025.

Based on Kathleen S. Wright Associates's 13F filing for Q3 2025, filed 10 Oct 2025.